Caricamento...
The Future of Interleukin-2: Enhancing Therapeutic Anticancer Vaccines
PURPOSE: The purpose of our efforts is to trigger the immune destruction .of established cancer. Interleukin (IL)-2 can mediate the regression of tumors in patients with melanoma and renal cell carcinoma. In animal models, the antitumor effects of IL-2 are mediated by T lymphocytes. Stimulation with...
Salvato in:
Autori principali: | , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
2000
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2538796/ https://ncbi.nlm.nih.gov/pubmed/10685664 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|